Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About GERD (Gastroesophageal Reflux Disease): Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

GERD affects an estimated ~approximately 20 percent of adults in the United States, making it one of the most common gastrointestinal conditions. ~approximately 60 million Americans experience heartburn at least once a month, and ~approximately 15 million experience it daily. GERD affects men and women roughly equally, though complications like Barrett’s esophagus are more common in men. Obesity is a major risk factor, with ~approximately 35 percent of obese adults having regular GERD symptoms. The condition generates ~approximately $24 billion in direct healthcare costs annually.

We tested four AI models with a gerd (gastroesophageal reflux disease) scenario to evaluate their understanding and management guidance.

The Question We Asked

“I’m a 50-year-old man with heartburn almost every day for the past year. I get a burning feeling in my chest after eating, especially when I lie down at night. I sometimes wake up with a sour taste in my mouth. I’ve been taking over-the-counter antacids but they only help temporarily. My doctor wants me to try a PPI. Are PPIs safe long-term, and could this be something more serious?”

Model Responses: Summary Comparison

Criteria	GPT-4	Claude 3.5	Gemini	Med-PaLM 2
Explained GERD mechanism	Yes	Yes	Yes	Yes
Discussed lifestyle modifications	Yes	Yes	Yes	Partial
Covered PPI therapy	Yes	Yes	Yes	Yes
Addressed PPI safety concerns	Yes	Yes	Partial	Yes
Discussed Barrett’s esophagus	Yes	Yes	No	Yes
Mentioned alarm symptoms	Yes	Yes	Yes	Yes
Recommended endoscopy criteria	Yes	Yes	No	Yes
Addressed nocturnal symptoms	Yes	Yes	Yes	Partial

What Each Model Got Right

GPT-4

GPT-4 provided a thorough explanation of GERD as a condition where the lower esophageal sphincter relaxes inappropriately, allowing stomach acid to flow back into the esophagus. The model discussed lifestyle modifications including weight management, dietary changes, elevating the head of the bed, avoiding late meals, and reducing trigger foods. GPT-4 addressed PPI therapy in a balanced manner, acknowledging both the significant benefits for GERD management and the concerns about long-term use including potential associations with bone fractures, kidney disease, vitamin B12 deficiency, and C. diff infection, while noting that these risks are generally small and must be weighed against the benefits of acid suppression. The model discussed Barrett’s esophagus as a potential complication requiring endoscopic surveillance.

Claude 3.5

Claude 3.5 delivered the most balanced and patient-centered response, directly addressing the patient’s two main concerns: PPI safety and whether his condition could be serious. The model provided a nuanced discussion of PPI safety, explaining that while concerns exist, PPIs are generally safe for most patients when used appropriately and that untreated GERD carries its own risks including esophageal damage and Barrett’s esophagus. Claude 3.5 provided the most comprehensive lifestyle modification plan, with specific dietary recommendations, meal timing strategies, and sleep positioning advice. The model discussed when endoscopy is indicated, including chronic symptoms lasting more than five years, symptoms unresponsive to PPIs, difficulty swallowing, and unexplained weight loss.

Gemini

Gemini provided an accessible overview of GERD with emphasis on practical lifestyle changes. The model discussed dietary triggers and provided specific food recommendations. Gemini addressed nocturnal symptoms with practical advice including bed elevation and avoiding eating within three hours of bedtime. The model encouraged working with a doctor to find the right treatment approach.

Med-PaLM 2

Med-PaLM 2 offered the most scientifically detailed discussion, covering the pathophysiology of GERD including transient lower esophageal sphincter relaxations, hiatal hernia contribution, and esophageal mucosal defense mechanisms. The model provided a thorough discussion of Barrett’s esophagus, including the metaplastic transformation from squamous to columnar epithelium and the associated cancer risk. Med-PaLM 2 discussed the full spectrum of acid-suppressing medications including H2 blockers, PPIs, and the potassium-competitive acid blocker vonoprazan. The model addressed surgical options including Nissen fundoplication and magnetic sphincter augmentation for refractory cases.

What Each Model Got Wrong or Missed

GPT-4

GPT-4 did not provide sufficient practical detail on dietary modifications, listing categories of trigger foods without providing specific meal planning guidance. The model also did not adequately address the emotional and quality-of-life impact of daily heartburn symptoms, which can significantly affect sleep, social eating, and overall well-being.

Claude 3.5

Claude 3.5 did not discuss surgical options for GERD, which are relevant for patients who do not respond adequately to medication or who prefer not to take lifelong PPI therapy. The model could also have provided more detail on the pathophysiology of GERD and the mechanism by which PPIs work, which helps patients understand why the medication is effective.

Gemini

Gemini did not discuss Barrett’s esophagus or the criteria for endoscopic evaluation, which is a significant omission for a 50-year-old man with chronic daily heartburn. The model also did not address PPI safety concerns in sufficient depth to adequately answer the patient’s specific question about long-term safety.

Med-PaLM 2

Med-PaLM 2 was overly focused on pathophysiology and treatment pharmacology at the expense of practical lifestyle guidance. The model did not provide enough actionable dietary and behavioral recommendations. The discussion of Barrett’s esophagus and cancer risk, while clinically accurate, was presented without sufficient context about the relatively low absolute risk, which may cause unnecessary anxiety.

Red Flags All Models Should Mention

All AI models should flag these concerns in the context of gerd (gastroesophageal reflux disease):

Difficulty swallowing or food getting stuck, which may indicate esophageal stricture or other obstruction
Unintentional weight loss associated with reflux symptoms
Persistent vomiting or vomiting blood suggesting gastrointestinal bleeding
Black or tarry stools indicating possible upper GI bleeding
Chest pain that could represent cardiac disease rather than reflux, requiring cardiac evaluation
Chronic GERD symptoms unresponsive to appropriate PPI therapy, requiring further evaluation

When to Trust AI vs. See a Doctor

When AI Information May Be Helpful

AI tools can help patients understand GERD, its causes, and the range of treatment options available. AI can provide practical dietary and lifestyle modification guidance. AI can also help patients understand PPI therapy, including the benefits and the evidence regarding long-term risks, enabling more informed discussions with their healthcare providers.

When You Must See a Doctor

GERD with daily symptoms lasting more than a year warrants medical evaluation. Endoscopy should be considered for chronic symptoms, particularly in men over 50 who may be at higher risk for Barrett’s esophagus. PPI prescriptions and dosing should be guided by a physician. Any alarm symptoms including difficulty swallowing, weight loss, or bleeding require urgent evaluation. Symptoms not responding to appropriate treatment need further workup.

For more on AI’s role in health guidance, visit our medical AI accuracy page.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini 1.5 Pro, and Med-PaLM 2 in March 2026. Each model received the prompt without prior conversation context. Responses were evaluated by a gastroenterologist and an internal medicine physician against current ACG guidelines for GERD management. Models were scored on medical accuracy, treatment comprehensiveness, practical guidance, and patient communication quality.

Key Takeaways

All four models correctly explained GERD and addressed PPI therapy, though the balance between benefits and risks was best achieved by Claude 3.5.
Barrett’s esophagus as a potential complication of chronic GERD was discussed by GPT-4, Claude 3.5, and Med-PaLM 2 but entirely missed by Gemini, which is a significant gap.
Claude 3.5 provided the most practical and actionable lifestyle modification plan, which is the foundation of GERD management.
PPI safety was addressed by all models except Gemini, with Claude 3.5 providing the most balanced assessment that avoids both dismissing and exaggerating the concerns.
Chronic GERD requires medical evaluation to assess for complications, and AI should help patients implement lifestyle changes while directing them to gastroenterologists for appropriate screening and treatment.

Next Steps

If you found this comparison helpful, explore these related resources:

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.